Company Filing History:
Years Active: 1987-1990
Title: H Mark Perks: Innovator in Microbial Detection Technologies
Introduction
H Mark Perks is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of microbial detection. With a total of 2 patents, he has developed innovative methods that enhance the identification and analysis of microorganisms.
Latest Patents
One of his latest patents is titled "Method for the detection of biologically active agents." This invention describes an apparatus and method for detecting the growth of microorganisms through infrared analysis of gas produced by the growth of the microorganism. In this method, a sample of the headspace gas in a vial containing a growth medium inoculated with a suspected microorganism is analyzed to determine the presence of carbon dioxide produced by the microorganism's growth.
Another significant patent is the "Lectin-coated latex agglutination assay for Neisseria gonorrhoeae." This method involves combining a microorganism with a latex particle coated with a specific lectin in a suitable fluid. The binding of the microorganism and lectin causes agglutination, which can be detected, allowing for the identification of the microorganism. This invention also includes a reagent that can be part of a kit for performing the method.
Career Highlights
H Mark Perks is associated with Becton Dickinson and Company Limited, where he applies his expertise in microbial detection technologies. His work has significantly contributed to advancements in the field, particularly in the identification of pathogens.
Collaborations
Throughout his career, H Mark Perks has collaborated with notable colleagues, including Joseph E Ahnell and Mark L Sussman. These collaborations have fostered innovation and development in microbial detection methods.
Conclusion
H Mark Perks stands out as an influential inventor in the realm of microbial detection technologies. His innovative patents and contributions to Becton Dickinson and Company Limited highlight his commitment to advancing scientific knowledge and improving public health.